Ernesto Aycardi
Keine laufenden Positionen mehr
Karriereverlauf von Ernesto Aycardi
Ehemalige bekannte Positionen von Ernesto Aycardi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| XENON PHARMACEUTICALS INC. | Technik-/Wissenschafts-/F&E-Leiter | 19.03.2018 | 23.04.2021 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01.01.2014 | 01.01.2018 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 01.01.2013 | 01.01.2014 |
| Biogen Canada, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2009 | 01.01.2013 |
| MERCK & CO., INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1998 | 01.01.2009 |
Ausbildung von Ernesto Aycardi
| Universidad Nacional de Colombia | Doctorate Degree |
Statistik
International
| Kanada | 3 |
| Vereinigte Staaten | 3 |
| Israel | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| XENON PHARMACEUTICALS INC. | Health Technology |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
| Biogen Canada, Inc. |
- Börse
- Insiders
- Ernesto Aycardi
- Erfahrung